Neuroscience

Karinoba Plus Film-Coated Tablet (37.5/150/200 mg)

Karinoba Plus Film-Coated Tablet 37.5
HF0517OA3240/022025
25/02/2026

Neuroscience

Karinoba Plus Film-Coated Tablet (37.5/150/200 mg)

Product Composition :

  • 150 mg of levodopa, 37.5 mg of carbidopa and 200 mg of entacapone

Product Details :

KARINOBA PLUS is indicated for the treatment of adult patients with Parkinson’s
disease and end of dose motor fluctuations not stabilized on levodopa/ dopa decarboxylase
(DOC) inhibitor treatment

Related Products

Ready to Partner with Elixir Pharma?

Join us in our mission to transform healthcare across Egypt, the Middle East, and Africa.